Skip to main content
SpringerLink
Log in

AEs with high- and standard-dose influenza vaccine in ESRD

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Layton JB, et al. Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease. Vaccine : 18 Jun 2020. Available from: URL: http://doi.org/10.1016/j.vaccine.2020.06.020

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

AEs with high- and standard-dose influenza vaccine in ESRD. Reactions Weekly 1811, 6 (2020). https://doi.org/10.1007/s40278-020-80229-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-80229-2

Search

Navigation